Aptamer-based lateral flow assay for point of care cortisol detection in sweat
暂无分享,去创建一个
[1] S. Aguirre,et al. Paper-based bioassays using gold nanoparticle colorimetric probes. , 2008, Analytical chemistry.
[2] P. Alam. ‘N’ , 2021, Composites Engineering: An A–Z Guide.
[3] M. Murtaugh,et al. High-level secretion of two antibody single chain Fv fragments by Pichia pastoris. , 1997, Journal of immunological methods.
[4] Nancy Kelley-Loughnane,et al. Tunable stringency aptamer selection and gold nanoparticle assay for detection of cortisol , 2014, Analytical and Bioanalytical Chemistry.
[5] 李俸化,et al. Cushing 氏 症候群 , 1980 .
[6] Brent D. Cameron,et al. An optical sensing approach for the noninvasive transdermal monitoring of cortisol , 2016, SPIE BiOS.
[7] Jason Heikenfeld,et al. Non‐invasive Analyte Access and Sensing through Eccrine Sweat: Challenges and Outlook circa 2016 , 2016 .
[8] D. Drolet,et al. An enzyme-linked oligonucleotide assay , 1996, Nature Biotechnology.
[9] Evan Russell,et al. The Detection of Cortisol in Human Sweat: Implications for Measurement of Cortisol in Hair , 2013, Therapeutic drug monitoring.
[10] Geertruida A. Posthuma-Trumpie,et al. Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey , 2009, Analytical and bioanalytical chemistry.
[11] Viswanadham Garimella,et al. Homogeneous detection of unamplified genomic DNA sequences based on colorimetric scatter of gold nanoparticle probes , 2004, Nature Biotechnology.
[12] M. Heilig. The NPY system in stress, anxiety and depression , 2004, Neuropeptides.
[13] C. O’Sullivan. Aptasensors – the future of biosensing? , 2002, Analytical and bioanalytical chemistry.
[14] W. Dhillo,et al. Free cortisol index is better than serum total cortisol in determining hypothalamic-pituitary-adrenal status in patients undergoing surgery. , 2003, The Journal of clinical endocrinology and metabolism.
[15] J. Whitworth,et al. Cushing, cortisol, and cardiovascular disease. , 2000, Hypertension.
[16] R. Quirion,et al. Neuropeptide Y (NPY) and depression: from animal studies to the human condition. , 2002, Life sciences.
[17] Seonghwan Lee,et al. Aptamers and Their Biological Applications , 2012, Sensors.
[18] R. Feldman,et al. Measuring cortisol in human psychobiological studies , 2007, Physiology & Behavior.
[19] Chii-Wann Lin,et al. Aptamer-based colorimetric detection of proteins using a branched DNA cascade amplification strategy and unmodified gold nanoparticles. , 2016, Biosensors & bioelectronics.
[20] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[21] Steve Near,et al. Detection of cortisol in saliva with a flow-filtered, portable surface plasmon resonance biosensor system. , 2008, Analytical chemistry.
[22] J. Whitworth,et al. Cardiovascular Consequences of Cortisol Excess , 2005, Vascular health and risk management.
[23] F. Reichmann,et al. Neuropeptide Y: A stressful review , 2016, Neuropeptides.
[24] J. Whitworth,et al. CORTISOL AND HYPERTENSION , 1998, Clinical and experimental pharmacology & physiology. Supplement.
[25] Andrew J Racher,et al. Antibody production. , 2006, Advanced drug delivery reviews.
[26] Weihong Tan,et al. Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors. , 2005, Analytical chemistry.
[27] Shekhar Bhansali,et al. Ultrasensitive detection of cortisol with enzyme fragment complementation technology using functionalized nanowire. , 2007, Biosensors & bioelectronics.
[28] John G. Bruno,et al. Aptamer-based point-of-care diagnostic platforms , 2017 .
[29] Juan Antonio Madrid,et al. Daily profile in two circadian markers “melatonin and cortisol” and associations with metabolic syndrome components , 2014, Physiology & Behavior.
[30] Tetsuya Osaka,et al. Invited) Industrialization Trial of a Biosensor Technology , 2017 .
[31] P. Alam. ‘S’ , 2021, Composites Engineering: An A–Z Guide.
[32] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[33] Yong Wang,et al. Aptamer-based colorimetric biosensing of dopamine using unmodified gold nanoparticles , 2011 .
[34] A. Steckl,et al. Stress Biomarkers in Biological Fluids and Their Point-of-Use Detection. , 2018, ACS sensors.
[35] R. Boonstra,et al. Measuring stress in wildlife: techniques for quantifying glucocorticoids , 2011, Oecologia.
[36] Tsuyoshi Murata,et al. {m , 1934, ACML.
[37] J Heikenfeld,et al. The microfluidics of the eccrine sweat gland, including biomarker partitioning, transport, and biosensing implications. , 2015, Biomicrofluidics.
[38] Ali Kemal Yetisen,et al. Paper-based microfluidic point-of-care diagnostic devices. , 2013, Lab on a chip.
[39] L. Selvakumar,et al. Nano RNA aptamer wire for analysis of vitamin B₁₂. , 2012, Analytical biochemistry.
[40] S. Jayasena. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.
[41] P. Alam. ‘W’ , 2021, Composites Engineering.
[42] Patricia Deuster,et al. Development of a sensitive microarray immunoassay for the quantitative analysis of neuropeptide Y. , 2012, Analytical chemistry.
[43] O. M. Edwards,et al. Changes in cortisol metabolism following rifampicin therapy. , 1974, Lancet.
[44] M. al’Absi,et al. Adrenocortical responses to psychological stress and risk for hypertension. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[45] X. Liu,et al. A Gold Nanoparticle‐Based Aptamer Target Binding Readout for ATP Assay , 2007 .
[46] H. Raff,et al. A Physiologic Approach to Diagnosis of the Cushing Syndrome , 2003, Annals of Internal Medicine.
[47] Giorgia Antonelli,et al. Cortisol assays and diagnostic laboratory procedures in human biological fluids. , 2009, Clinical biochemistry.
[48] Jorge L. Chávez,et al. Fast and Selective Plasmonic Serotonin Detection with Aptamer-Gold Nanoparticle Conjugates , 2017, Sensors.
[49] P. Alam. ‘G’ , 2021, Composites Engineering: An A–Z Guide.
[50] Miriam Jauset-Rubio,et al. Advances in aptamers-based lateral flow assays , 2017 .
[51] Joshua A. Hagen,et al. Aptamer-functionalized graphene-gold nanocomposites for label-free detection of dielectrophoretic-enriched neuropeptide Y , 2016 .
[52] Nancy Kelley-Loughnane,et al. Aptamer-functionalized nanoparticles for surface immobilization-free electrochemical detection of cortisol in a microfluidic device. , 2016, Biosensors & bioelectronics.
[53] Huixiang Li,et al. Label-free colorimetric detection of specific sequences in genomic DNA amplified by the polymerase chain reaction. , 2004, Journal of the American Chemical Society.
[54] Joshua E. Smith,et al. A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay , 2015, Journal of visualized experiments : JoVE.
[55] Shekhar Bhansali,et al. Recent advances in cortisol sensing technologies for point-of-care application. , 2014, Biosensors & bioelectronics.
[56] Reinhard Renneberg,et al. One-step quantitative cortisol dipstick with proportional reading. , 2003, Journal of immunological methods.
[57] P. Alam,et al. H , 1887, High Explosives, Propellants, Pyrotechnics.
[58] Danna Zhou,et al. d. , 1840, Microbial pathogenesis.
[59] P. Alam. ‘A’ , 2021, Composites Engineering: An A–Z Guide.
[60] Ramón Pamies,et al. Aggregation behaviour of gold nanoparticles in saline aqueous media , 2014, Journal of Nanoparticle Research.
[61] Shekhar Bhansali,et al. An LTCC-based microfluidic system for label-free, electrochemical detection of cortisol , 2013 .
[62] Hans Wolf,et al. An aptamer-based quartz crystal protein biosensor. , 2002, Analytical chemistry.
[63] Esther M. Sternberg,et al. Elevated Neuroimmune Biomarkers in Sweat Patches and Plasma of Premenopausal Women with Major Depressive Disorder in Remission: The POWER Study , 2008, Biological Psychiatry.